Literature DB >> 20162571

Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance.

Candice A Shaifer1, Jianhua Huang, Pengnain Charles Lin.   

Abstract

Glioblastoma multiforme (GBM) remains the most devastating neoplasm of the central nervous system and has a dismal prognosis. Ionizing radiation represents an effective therapy for GBM, but radiotherapy remains only palliative because of radioresistance. In this study, we demonstrate that glioma cells participate in tumor vascularization and contribute to vascular radioresistance. Using a 3-dimensional coculture system, we observed an intimate interaction of glioma cells with endothelial cells whereby endothelial cells form vascular structures, followed by the recruitment and vascular patterning of glioma cells. In addition, tumor cells stabilize the vascular structures and render them radioresistant. Blocking initial endothelial vascular formation with endothelial-specific inhibitors prevented tumor cells from forming any structures. However, these inhibitors exhibited minimum effects on vascular structures formed by tumor cells, due to the absence of the targeted receptors on tumor cells. Consistent with the in vitro findings, we show that glioma cells form perfused blood vessels in xenograft tumor models. Together, these data suggest that glioma cells mimic endothelial cells and incorporate into tumor vasculature, which may contribute to radioresistance observed in GBM. Therefore, interventions aimed at the glioma vasculature should take into consideration the chimeric nature of the tumor vasculature.

Entities:  

Mesh:

Year:  2010        PMID: 20162571      PMCID: PMC2932815          DOI: 10.1002/ijc.25249

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

Authors:  P Lin; P Polverini; M Dewhirst; S Shan; P S Rao; K Peters
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

Authors:  T A Fong; L K Shawver; L Sun; C Tang; H App; T J Powell; Y H Kim; R Schreck; X Wang; W Risau; A Ullrich; K P Hirth; G McMahon
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Authors:  C Suri; P F Jones; S Patan; S Bartunkova; P C Maisonpierre; S Davis; T N Sato; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

Authors:  Jann N Sarkaria; Brett L Carlson; Mark A Schroeder; Patrick Grogan; Paul D Brown; Caterina Giannini; Karla V Ballman; Gaspar J Kitange; Abjahit Guha; Ajay Pandita; C David James
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

6.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2.

Authors:  Bo Hu; Ping Guo; Quan Fang; Huo-Quan Tao; Degui Wang; Motoo Nagane; Hui-Jein Su Huang; Yuji Gunji; Ryo Nishikawa; Kari Alitalo; Webster K Cavenee; Shi-Yuan Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

8.  Prostate-specific membrane antigen directed selective thrombotic infarction of tumors.

Authors:  Cheng Liu; Haining Huang; Fernando Doñate; Craig Dickinson; Richard Santucci; Amr El-Sheikh; Robert Vessella; Thomas S Edgington
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

9.  Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis.

Authors:  A Stratmann; W Risau; K H Plate
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  17 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  Vasculogenic Mimicry in Clinically Non-functioning Pituitary Adenomas: a Histologic Study.

Authors:  Joseph Di Michele; Fabio Rotondo; Kalman Kovacs; Luis V Syro; George M Yousef; Michael D Cusimano; Antonio Di Ieva
Journal:  Pathol Oncol Res       Date:  2017-01-13       Impact factor: 3.201

Review 3.  The Translational Significance of the Neurovascular Unit.

Authors:  Heather L McConnell; Cymon N Kersch; Randall L Woltjer; Edward A Neuwelt
Journal:  J Biol Chem       Date:  2016-12-05       Impact factor: 5.157

4.  The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma.

Authors:  Randy D'Amico; Liang Lei; Benjamin C Kennedy; Julia Sisti; Victoria Ebiana; Celina Crisman; James G Christensen; Orlando Gil; Steven S Rosenfeld; Peter Canoll; Jeffrey N Bruce
Journal:  Neurol Res       Date:  2012-03-05       Impact factor: 2.448

5.  Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures.

Authors:  Marie-France Nissou; Michèle El Atifi; Audrey Guttin; Catherine Godfraind; Caroline Salon; Emmanuel Garcion; Boudewijn van der Sanden; Jean-Paul Issartel; François Berger; Didier Wion
Journal:  J Neurooncol       Date:  2013-03-31       Impact factor: 4.130

Review 6.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

Review 7.  Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.

Authors:  Yasushi Soda; Chad Myskiw; Amy Rommel; Inder M Verma
Journal:  J Mol Med (Berl)       Date:  2013-03-20       Impact factor: 4.599

Review 8.  Mechanisms of glioma-associated neovascularization.

Authors:  Matthew E Hardee; David Zagzag
Journal:  Am J Pathol       Date:  2012-08-02       Impact factor: 4.307

Review 9.  Radioresistance of glioma stem cells: intrinsic characteristic or property of the 'microenvironment-stem cell unit'?

Authors:  Mariella Mannino; Anthony J Chalmers
Journal:  Mol Oncol       Date:  2011-05-20       Impact factor: 6.603

Review 10.  Modulation of tumor tolerance in primary central nervous system malignancies.

Authors:  Theodore S Johnson; David H Munn; Bernard L Maria
Journal:  Clin Dev Immunol       Date:  2012-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.